| Elana Lieberman, MA CCC-SLP | |
|
231 Crosswicks Rd, Bordentown, NJ 08505-2602 | |
| (609) 372-4613 | |
| Not Available |
| Full Name | Elana Lieberman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 231 Crosswicks Rd, Bordentown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114798998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00573700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elana Lieberman, MA CCC-SLP 20 Lernard Rd, Manalapan, NJ 07726-7912 Ph: (917) 586-3917 | Elana Lieberman, MA CCC-SLP 231 Crosswicks Rd, Bordentown, NJ 08505-2602 Ph: (609) 372-4613 |
News Archive
Despite the numerous medical advances that happen every day, the infant mortality rate in the United States is still higher than most European countries. While experts believe this is closely linked to the growing rate of pre-term births, researchers are committed to finding ways to make labor and delivery safer. Northwestern Medicine- researchers are examining a new device that may support improved newborn health at delivery through closer monitoring of infant oxygen use during labor.
Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its clinical development of ALT-801, a novel tumor-targeted immunotherapeutic designed to improve the efficacy and safety of the FDA-approved anticancer cytokine, interleukin-2 (IL-2).
Hierarchies exist across all human and animal societies, organized by what behavioral scientists refer to as dominance. Dominant individuals tend to climb higher up the hierarchy ladder of their particular society, earning priority access to resources.
A ground-breaking new research approach to understanding the cellular processes of Alzheimer's and other degenerative diseases has revealed a promising pathway to the development of new types of drugs for these diseases.
Open access publisher BioMed Central is proud to announce the launch of Acta Neuropathologica Communications (ANC). ANC will publish work on pathology and mechanisms of neurological disease using structural, molecular and cellular techniques.
› Verified 6 days ago
Ariana Marie Shanks, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Crosswicks Rd Ste 4, Bordentown, NJ 08505 Phone: 609-372-4613 | |
Mrs. Roberta Schwartz Israelsky, M.A. CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Crosswicks Rd, Suite 4, Bordentown, NJ 08505 Phone: 609-372-4613 | |
Julie Barry, MA CC -SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Crosswicks Rd Ste 4, Bordentown, NJ 08505 Phone: 609-372-4613 | |
Mrs. Erin Goodwin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Crosswicks Rd, Suite 4, Bordentown, NJ 08505 Phone: 609-372-4613 | |
Taylor Nicole Roberts, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Crosswicks Rd Ste 4, Bordentown, NJ 08505 Phone: 609-372-4613 | |
Brain Life Connection Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4308 Stefanie Dr, Bordentown, NJ 08505 Phone: 508-296-4301 |